ÆÑ¹«Ó¢ - ÖÆÒ©¼¼ÊõµÄ´«²¥Õß GMPÀíÂÛµÄʵ¼ùÕß

ËÑË÷
²é¿´: 4156|»Ø¸´: 9
ÊÕÆð×ó²à

[ÖÊÁ¿¿ØÖÆQC] ¹ØÓÚÃð¾ú¹ñÈ¡Ñù

[¸´ÖÆÁ´½Ó]
ҩͽ
·¢±íÓÚ 2013-7-19 11:13:13 | ÏÔʾȫ²¿Â¥²ã |ÔĶÁģʽ

»¶Ó­Äú×¢²áÆÑ¹«Ó¢

ÄúÐèÒª µÇ¼ ²Å¿ÉÒÔÏÂÔØ»ò²é¿´£¬Ã»ÓÐÕʺţ¿Á¢¼´×¢²á

x
Çë½Ì£º´óÊäÒºÒ»Åú²úÆ·4¸öÃð¾ú¹ñÃð¾ú£¬ÎÞ¾úÈ¡ÑùÊÇÿ¹ñ¸÷È¡30Æ¿£¬»¹ÊÇÔÚ4¸ö¹ñµÄÀäµã¶¼È¡ÑùµÄǰÌáÏ£¬4¸ö¹ñ¹²È¡Ñù30Æ¿£¿
Ò©Ê¿
·¢±íÓÚ 2013-7-19 11:23:27 | ÏÔʾȫ²¿Â¥²ã
Äã˵µÄÊÇÕâ¸ö£¿

µÚÊ®ËÄÕ  ÖÊÁ¿¿ØÖÆ
¡¡¡¡¡¡µÚ°ËÊ®Ìõ  ÎÞ¾ú¼ì²éµÄÈ¡Ñù¼Æ»®Ó¦µ±¸ù¾Ý·çÏÕÆÀ¹À½á¹ûÖÆ¶¨£¬ÑùÆ·Ó¦µ±°üÀ¨Î¢ÉúÎïÎÛȾ·çÏÕ×î´óµÄ²úÆ·¡£ÎÞ¾ú¼ì²éÑùÆ·µÄÈ¡ÑùÖÁÉÙÓ¦µ±·ûºÏÒÔÏÂÒªÇó£º
¡¡¡¡£¨Ò»£©ÎÞ¾ú¹à×°²úÆ·µÄÑùÆ·±ØÐë°üÀ¨×î³õ¡¢×îÖÕ¹à×°µÄ²úÆ·ÒÔ¼°¹à×°¹ý³ÌÖз¢Éú½Ï´óÆ«²îºóµÄ²úÆ·£»
¡¡¡¡£¨¶þ£©×îÖÕÃð¾ú²úÆ·Ó¦µ±´Ó¿ÉÄܵÄÃð¾úÀäµã´¦È¡Ñù£»
¡¡¡¡£¨Èý£©Í¬Ò»Åú²úÆ·¾­¶à¸öÃð¾úÉ豸»òͬһÃð¾úÉ豸·Ö´ÎÃð¾úµÄ£¬ÑùÆ·Ó¦µ±´Ó¸÷¸ö/´ÎÃð¾úÉ豸ÖгéÈ¡¡£

ÆÀ·Ö

²ÎÓëÈËÊý 1½ð±Ò +4 ÊÕÆð ÀíÓÉ
ÖÙÏÄÇïÒ¹ÔÆ + 4 ÎÒ¾Íϲ»¶ÕâÖֻشð£¬Óгö´¦ÓÐÒ»¾ä£¬Ò»Ä¿ÁËÈ»

²é¿´È«²¿ÆÀ·Ö

»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2013-7-19 11:26:45 | ÏÔʾȫ²¿Â¥²ã
2010Äê Ò©Æ·GMPÖ¸ÄÏ£ºÎÞ¾úÒ©Æ·  p326
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
·¢±íÓÚ 2013-7-19 11:34:19 | ÏÔʾȫ²¿Â¥²ã
·Ö4¹ñÃð¾ú£¬¾ÍÊÇ4´Î²»Í¬µÄÃð¾ú£¬ÈçºÎÀ´±£Ö¤Ã¿´ÎÃð¾úµÄ²úÆ·µÄÎÞ¾ú״̬£¬¾ÍÐèÒª¶Ôÿ´ÎÃð¾úºóµÄ²úÆ·½øÐÐÎÞ¾ú¼ì²â£¬¾ÍÊǶÔÿ¹ñ¶¼½øÐÐÈ¡Ñù¡£
ÖÕ¶ËÃð¾ú²úÆ··Ö¹ñÃ𣬾Ͳ»Äܼòµ¥µÄ¿´Ò»Åú²úÆ·µÄÎÊÌ⣬ºËÐÄÊÇÃð¾ú¡£
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2013-7-20 11:00:46 | ÏÔʾȫ²¿Â¥²ã
¡° ÖÙÏÄÇïÒ¹ÔÆ         + 4        ÎÒ¾Íϲ»¶ÕâÖֻشð£¬Óгö´¦ÓÐÒ»¾ä£¬Ò»Ä¿ÁËÈ»¡±ËûÃÇ×Ü˵ÎÒ¡£²»»Ø´ðÎÊÌ⣬¾­³£·í´Ì±ðÈË¡£¡£¡£¡£{:soso_e154:}
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
 Â¥Ö÷| ·¢±íÓÚ 2013-7-20 16:12:19 | ÏÔʾȫ²¿Â¥²ã
лл¸÷λÀÏʦ£¬ÎÒÃÇÒ»Ö±Êǰ´Ã¿¹ñ·Ö±ðÈ¡¹æ¶¨Á¿30Æ¿½øÐÐÎÞ¾ú¼ìÑ飬µ«ÐÂÐÞ¶©Ò©Æ·GMP¼¼ÊõÎÊÌâ½â´ðÒ»ÊéÖÐÊÇÕâÑùÃèÊöµÄ£º
2001.jpg
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ҩͽ
 Â¥Ö÷| ·¢±íÓÚ 2013-7-20 16:18:13 | ÏÔʾȫ²¿Â¥²ã
89Ò³78ÌõÖеÄ×ö·¨£¬²»ÖªÊÇ·ñÐеÃͨ£¿
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

·¢±íÓÚ 2013-7-20 16:23:55 | ÏÔʾȫ²¿Â¥²ã
ѧϰѧϰ¡£
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2016-6-28 21:04:55 | ÏÔʾȫ²¿Â¥²ã
±¾Ìû×îºóÓÉ beiwei5du ÓÚ 2016-6-28 21:22 ±à¼­
chengjing ·¢±íÓÚ 2013-7-20 16:12
лл¸÷λÀÏʦ£¬ÎÒÃÇÒ»Ö±Êǰ´Ã¿¹ñ·Ö±ðÈ¡¹æ¶¨Á¿30Æ¿½øÐÐÎÞ¾ú¼ìÑ飬µ«ÐÂÐÞ¶©Ò©Æ·GMP¼¼ÊõÎÊÌâ½â´ðÒ»ÊéÖÐÊÇÕâÑù ...

¡°ÎÞ¾ú¼ì²é°´Åú´Î½øÐм´¿É£¬²»±Ø°´Ã¿¸öÃð¾ú¹ó´Îµ¥¶À½øÐС±Ñ§Ï°ÁËCan there be any exceptions to this rule?For large-volume parenterals where the sterilisation cycle has been qualified with an overkill level, an alternative sampling plan in accordance with a specific internal procedure agreed with the supervisory authority can be accepted (unless already specified in the marketing authorisation).
This procedure should state the need to sample from each steriliser load including the coolest location identified during the steriliser qualification. The number of samples per load should be defined based on a risk-based approach and the overall number of samples per batch should conform to European Pharmacopoeia requirements, section 2.6.1.3. An alternative option, which would require a variation to relevant existing marketing authorisations, would be to introduce a system of parametric release, thereby avoiding the need to carry out the sterility test.
Õâ¸öÊDz»ÊÇ˵×ܵÄÊýÁ¿Âú×ã¼´¿É£¬¿ÉÃð¾úload¿ÉÒÔ¸ù¾Ý·çÏÕµ÷ÕûÊýÁ¿£¿

»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

Ò©Ê¿
·¢±íÓÚ 2016-6-28 21:07:37 | ÏÔʾȫ²¿Â¥²ã
²»ÖªµÀLZÕâ¸öÎÊÌâÊÇÈçºÎ½â¾öµÄÄØ£¿£¿Ð»Ð»£¡
»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

ÄúÐèÒªµÇ¼ºó²Å¿ÉÒÔ»ØÌû µÇ¼ | Á¢¼´×¢²á

±¾°æ»ý·Ö¹æÔò

×·¢ÌûÉùÃ÷
1¡¢±¾Õ¾Îª¼¼Êõ½»Á÷ÂÛ̳£¬·¢ÌûµÄÄÚÈݾßÓл¥¶¯ÊôÐÔ¡£ÄúÔÚ±¾Õ¾·¢²¼µÄÄÚÈÝ£º
¢ÙÔÚÎÞÈ˻ظ´µÄÇé¿öÏ£¬¿ÉÒÔͨ¹ý×ÔÖúɾÌû¹¦ÄÜËæÊ±É¾³ý£¨×ÔÖúɾÌû¹¦ÄÜ¹Ø±ÕÆÚ¼ä£¬¿ÉÒÔÁªÏµ¹ÜÀíԱ΢ÐÅ£º8542508 ´¦Àí¡££©
¢ÚÔÚÓÐÈ˻ظ´ºÍÌÖÂÛµÄÇé¿öÏ£¬Ö÷ÌâÌûºÍ»Ø¸´ÄÚÈÝÒѹ¹³ÉÒ»¸ö²»¿É·Ö¸îµÄÕûÌ壬Äú½«²»ÄÜÖ±½Óɾ³ý¸ÃÌû¡£
2¡¢½ûÖ¹·¢²¼ÈκÎÉæÕþ¡¢Éæ»Æ¶Ä¶¾¼°ÆäËûÎ¥·´¹ú¼ÒÏà¹Ø·¨ÂÉ¡¢·¨¹æ¡¢¼°±¾Õ¾°æ¹æµÄÄÚÈÝ£¬ÏêÇéÇë²ÎÔÄ¡¶ÆÑ¹«Ó¢ÂÛ̳×Ü°æ¹æ¡·¡£
3¡¢ÄúÔÚ±¾Õ¾·¢±í¡¢×ªÔصÄÈκÎ×÷Æ·½ö´ú±íÄú¸öÈ˹۵㣬²»´ú±í±¾Õ¾¹Ûµã¡£²»ÒªµÁÓÃÓаæÈ¨ÒªÇóµÄ×÷Æ·£¬×ªÌùÇë×¢Ã÷À´Ô´£¬·ñÔòÎÄÔð×Ô¸º¡£
4¡¢ÇëÈÏÕæÔĶÁÉÏÊöÌõ¿î£¬Äú·¢Ìû¼´´ú±í½ÓÊÜÉÏÊöÌõ¿î¡£

QQ|ÊÖ»ú°æ|ÆÑ¹«Ó¢|ouryao|ÆÑ¹«Ó¢ ( ¾©ICP±¸14042168ºÅ-1 )  ÔöÖµµçÐÅÒµÎñ¾­ÓªÐí¿ÉÖ¤±àºÅ£º¾©B2-20243455  »¥ÁªÍøÒ©Æ·ÐÅÏ¢·þÎñ×ʸñÖ¤Êé±àºÅ£º(¾©)-·Ç¾­ÓªÐÔ-2024-0033

GMT+8, 2025-9-17 23:25

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

ÉùÃ÷£ºÆÑ¹«Ó¢ÍøÕ¾ËùÉæ¼°µÄÔ­´´ÎÄÕ¡¢ÎÄ×ÖÄÚÈÝ¡¢ÊÓÆµÍ¼Æ¬¼°Ê×·¢×ÊÁÏ£¬°æÈ¨¹é×÷Õß¼°ÆÑ¹«Ó¢ÍøÕ¾ËùÓУ¬×ªÔØÒªÔÚÏÔÖøÎ»ÖñêÃ÷À´Ô´¡°ÆÑ¹«Ó¢¡±£»½ûÖ¹ÈκÎÐÎʽµÄÉÌÒµÓÃ;¡£Î¥·´ÉÏÊöÉùÃ÷µÄ£¬±¾Õ¾¼°×÷Õß½«×·¾¿·¨ÂÉÔðÈΡ£
¿ìËٻظ´ ·µ»Ø¶¥²¿ ·µ»ØÁбí